Non-hospitalised | Non-ICU ward | ICU ward | |
Predictors | OR (95% CI) | OR (95% CI) | OR (95% CI) |
Demographics | |||
Male | 1.89 (1.59 to 2.25)*** | 1.30 (1.11 to 1.52)** | |
Age group 30–35 | 1.66 (0.60 to 4.55) | 1.40 (0.53 to 3.66) | 1.13 (0.47 to 2.70) |
Age group 35–40 | 3.00 (1.24 to 7.27)* | 1.65 (0.68 to 4.01) | 1.71 (0.76 to 3.86) |
Age group 40–45 | 5.82 (2.63 to 12.88)*** | 1.83 (0.80 to 4.17) | 1.74 (0.77 to 3.95) |
Age group 45–50 | 10.81 (5.11 to 22.86)*** | 2.66 (1.22 to 5.79)* | 1.93 (0.90 to 4.12) |
Age group 50–55 | 15.48 (7.43 to 32.25)*** | 2.85 (1.33 to 6.10)** | 2.81 (1.33 to 5.94)** |
Age group >55 | 65.92 (33.39 to 130.15)*** | 11.65 (5.80 to 23.41)*** | 4.42 (2.26 to 8.66)*** |
HDI | 0.03 (0.001 to 0.38)** | ||
Comorbidities | |||
Heart disease | 2.33 (1.86 to 2.91)*** | 1.87 (1.54 to 2.26)*** | 2.11 (1.63 to 2.73)*** |
Hypertension | 1.18 (0.97 to 1.43) | ||
Diabetes | 1.84 (1.49 to 2.26)*** | 1.42 (1.19 to 1.71)*** | 1.66 (1.32 to 2.11)*** |
Neurological disease | 2.59 (1.75 to 3.83)*** | 3.39 (2.44 to 4.71)*** | 2.16 (1.35 to 3.46)** |
Immunodeficiency | 1.97 (1.13 to 3.43)* | ||
Kidney disease | 2.22 (1.39 to 3.56)*** | 2.39 (1.60 to 3.56)*** | 2.13 (1.36 to 3.35)** |
Chronic obstructive pulmonary disease | 1.65 (1.19 to 2.29)** | 2.20 (1.70 to 2.85)*** | 1.48 (1.04 to 2.12)** |
Neoplastic disease | 2.12 (1.18 to 3.82)* | 3.19 (2.15 to 4.71)*** | 3.22 (1.75 to 5.93)*** |
Obesity | 2.18 (1.67 to 2.85)*** | ||
Observations | 95 352 | 5484 | 2126 |
AIC | 5422.39 | 4217.9 | 2317.1 |
*P<0.05, **P<0.01, ***p<0.001.
AIC, Akaike information criterion; HDI, Human Development Index; ICU, intensive care unit.